Lisette Okkels Jensen

Showing 1-20 of 20 articles

Coronary interventions

Thin- versus thick-strut polymer-free biolimus-eluting stents: the BioFreedom QCA randomised trial

Sabaté M, Okkels Jensen L, Tilsted H, Moreno R, García del Blanco B, Macaya C, Pérez de Prado A, Cequier A, Pérez-Fuentes P, Schütte D, Costa R, Stoll H, Flensted Lassen J

June 25, 2021 | 10.4244/EIJ-D-20-01162

Coronary interventions

Ten-year outcomes from a randomised comparison of zotarolimus-eluting and sirolimus-eluting stents: the SORT OUT III study

Pareek M, Madsen M, Warnakula Olesen K, Okkels Jensen L, Christiansen E, Dalby Kristensen S, Flensted Lassen J, Thuesen L, Bøtker H, Maeng M

December 6, 2019 | 10.4244/EIJ-D-19-00503

Interventions for heart failure

Impella CP or VA-ECMO in profound cardiogenic shock: left ventricular unloading and organ perfusion in a large animal model

Moller-Helgestad OK, Hyldebrandt JA, Banke A, Rud CS, Udesen NLJ, Linde L, Okkels Jensen L, Schmidt H, Ravn HB, Moller JE

February 7, 2019 | 10.4244/EIJ-D-18-00684

Coronary interventions

Three-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and a durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction (TROFI II trial)

Katagiri Y, Onuma Y, Asano T, Iñiguez A, Okkels Jensen L, Cequier A, Hofma S, Christiansen E, Suttorp M, Brugaletta S, Räber L, Sabaté M, Windecker S, Serruys P, Räber L, Sabaté M, Serruys P

December 7, 2018 | 10.4244/EIJ-D-18-00839

STEMI

One-year rehospitalisation after percutaneous coronary intervention: a retrospective analysis

Hansen KN, Bendix K, Antonsen L, Veien K, Maeng M, Junker A, Christiansen E, Kahlert J, Terkelsen C, Christensen LB, Fallesen C, Bøtker H, Okkels Jensen L

October 19, 2018 | 10.4244/EIJ-D-17-00800

Interventions for heart failure

Percutaneous biventricular cardiac assist device in cardiogenic shock and refractory cardiac arrest

Ellert J, Jensen MJ, Okkels Jensen L, Moller JE

April 6, 2018 | 10.4244/EIJ-D-17-00637

How should I treat a bioresorbable vascular scaffold edge restenosis and intra-scaffold dissection?

Fallesen C, Antonsen L, Thayssen P, Okkels Jensen L

February 20, 2018 | 10.4244/EIJ-D-17-00309

Two-year outcome after biodegradable polymer sirolimus- and biolimus-eluting coronary stents (from the randomised SORT OUT VII trial)

Okkels Jensen L, Maeng M, Raungaard B, Hansen K, Kahlert J, Jensen S, Hansen H, Flensted Lassen J, Bøtker H, Christiansen E

January 19, 2018 | 10.4244/EIJ-D-17-00731

Final five-year outcomes after implantation of biodegradable polymer-coated biolimus-eluting stents versus durable polymer-coated sirolimus-eluting stents

Jakobsen L, Christiansen E, Maeng M, Hansen K, Kristensen SD, Bøtker H, Terkelsen C, Jensen S, Raungaard B, Madsen M, Flensted Lassen J, Okkels Jensen L

December 20, 2017 | 10.4244/EIJ-D-17-00434

Coronary interventions

Arterial healing following primary PCI using the Absorb everolimus-eluting bioresorbable vascular scaffold (Absorb BVS) versus the durable polymer everolimus-eluting metallic stent (XIENCE) in patients with acute ST-elevation myocardial infarction: rationale and design of the randomised TROFI II study

Räber L, Onuma Y, Brugaletta S, Garcia-Garcia H, Backx B, Iñiguez A, Okkels Jensen L, Cequier-Fillat A, Pilgrim T, Christiansen E, Hofma S, Suttorp M, Serruys P, Sabaté M, Windecker S

July 20, 2016 | 10.4244/EIJY15M08_03

Coronary interventions

Outcome with invasive versus medical treatment of stable coronary artery disease: influence of perfusion defect size, ischaemia, and ejection fraction

Simonsen J, Johansen A, Gerke O, Mickley H, Thomassen A, Hess S, Rask C, Tamadoni M, Okkels Jensen L, Hallas J, Vach W, Hoilund-Carlsen P

February 19, 2016 | 10.4244/EIJV11I10A226

Very late stent thrombosis caused by neoatherosclerotic plaque rupture

Hougaard M, Thayssen P, Hansen H, Okkels Jensen L

April 20, 2015 | 10.4244/EIJV10I12A251

Outcomes after revascularisation with everolimus- and sirolimus-eluting stents in patients with acute coronary syndromes and stable angina pectoris: a substudy of the SORT OUT IV trial

Antonsen L, Thayssen P, Hansen H, Maeng M, Tilsted H, Bøtker H, Ravkilde J, Madsen M, Sørensen H, Thuesen L, Flensted Lassen J, Okkels Jensen L

June 20, 2014 | 10.4244/EIJV10I2A35

Influence of high-dose lipid lowering treatment compared to low-dose lipid lowering treatment on plaque composition assessed by intravascular ultrasound virtual histology in patients with ST-segment elevation acute myocardial infarction: the VIRHISTAMI trial

Egede R, Okkels Jensen L, Hansen H, Hansen K, Junker A, Thayssen P

February 22, 2013 | 10.4244/EIJV8I10A182

Jakobsen L, Niemann T, Thorsgaard N, Nielsen T, Thuesen L, Flensted Lassen J, Okkels Jensen L, Thayssen P, Ravkilde J, Tilsted H, Mehnert F, Johnsen SP

December 28, 2012 | 10.4244/EIJV8I8A139

The risk and prognostic impact of definite stent thrombosis or in-stent restenosis after coronary stent implantation

Thayssen P, Okkels Jensen L, Flensted Lassen J, Tilsted H, Kaltoft A, Christiansen E, Hansen K, Ravkilde J, Maeng M, Krusell L, Madsen M, Sørensen H, Thuesen L

September 28, 2012 | 10.4244/EIJV8I5A91

Culprit only or multivessel percutaneous coronary interventions in patients with ST-segment elevation myocardial infarction and multivessel disease

Okkels Jensen L, Thayssen P, Farkas D, Hougaard M, Terkelsen C, Tilsted H, Maeng M, Junker A, Flensted Lassen J, Horv E, Sørensen H, Thuesen L

August 24, 2012 | 10.4244/EIJV8I4A72

Late lumen loss and intima hyperplasia after sirolimus-eluting and zotarolimus-eluting stent implantation in diabetic patients: the diabetes and drug-eluting stent (DiabeDES III) angiography and intravascular ultrasound trial

Okkels Jensen L, Maeng M, Thayssen P, Villadsen A, Krusell L, Bøtker H, Pedersen K, Aaroe J, Christiansen E, Vesterlund T, Hansen K, Ravkilde J, Tilsted H, Flensted Lassen J, Thuesen L

July 29, 2011 | 10.4244/EIJV7I3A56

Paclitaxel and sirolimus eluting stents versus bare metal stents: long-term risk of stent thrombosis and other outcomes

Okkels Jensen L, Tilsted H, Thayssen P, Kaltoft A, Maeng M, Flensted Lassen J, Noerregaard Hansen K, Madsen M, Ravkilde J, Johnsen S, Sørensen H, Thuesen L

April 12, 2010

Between-centre reproducibility of volumetric intravascular ultrasound radiofrequency-based analyses in mild-tomoderate coronary atherosclerosis: an international multicentre study

Huisman J, Egede R, Rdzanek A, Böse D, Erbel R, Kochman J, Okkels Jensen L, Van de Palen J, Hartmann M, Mintz G, von Birgelen C

April 12, 2010

Latest news

NEW ISSUE

State of the Art on ViV-TAVI; Transseptal Punctures; Endovascular Closure and TF-TAVI; Percutaneous PVL Closure: Long-Term Outcomes; and more

October 20, 2021

STATE OF THE ART

Valve-in-valve TAVI: a practical overview

Giuseppe Tarantini et al.

October 20, 2021

AHEAD OF PRINT

Impact of LVOT calcification in transfemoral TAVI patients

L. Waldschmidt et al.

October 19, 2021

AHEAD OF PRINT

Serum caffeine causes adenosine-induced FFR overestimation

Hideaki Tanaka et al.

Transcatheter Paravalvular Leak Closure: Catch Me If You Can

Thomas Pilgrim et al.

October 20, 2021

STATE OF THE ART

Glucose-Lowering Therapy in Patients undergoing Percutaneous Coronary Intervention

Isabelle Johansson et al.